報價延遲最少15分鐘:2025/06/04 15:17 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
23.75 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.63/--
|
|
企業價值
1.78B
|
| 資產負債 |
|
每股賬面淨值
5.09
|
| 現金流量 |
|
現金流量率
0.02
|
| 損益表 |
|
收益
207.54M
|
|
每股收益
2.72
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/04 15:17 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations. |